Meridian bioscience stock.
Jan 31, 2023 · The estimated Net Worth of John P. Kenny is at least 17.5 百万$ dollars as of 24 June 2022. Mr Kenny owns over 74,996 units of Meridian Bioscience stock worth over 11,093,515$ and over the last 5 years he sold VIVO stock worth over 4,939,280$. In addition, he makes 1,508,705$ as Pres、 CEO & Director at Meridian Bioscience.
May 9, 2021 · The stock of Meridian Bioscience (NAS:VIVO, 30-year Financials) shows every sign of being fairly valued, according to GuruFocus Value calculation. Dec 3, 2020 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ... Jan 31, 2023 · John has made over 6 trades of the Meridian Bioscience stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VIVO stock worth $37,950 on 25 February 2020.About Life Science. Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic products and critical raw materials. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy, and simplicity that redefine the ...
Meridian is an Ohio corporation and, therefore, governed by the corporate laws of Ohio. Since its stock is publicly traded on Nasdaq and it files reports with the Securities and Exchange Commission, it is also subject to NASD rules as well as various provisions of federal securities laws as recently changed by the Sarbanes-Oxley Act. 37.23M. MSFT. 378.61. +0.31%. 20.54M. View today's Meridian Bioscience Inc stock price and latest VIVO news and analysis. Create real-time notifications to follow any changes in the live stock price.
Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has entered into a side letter with the buyer ...
Meridian Bioscience announced July 7 it's entered into a definitive merger agreement to be acquired by a pair of South Korean-based firms, SD Biosensor and SJL Partners, in a deal valued at $1.53 ...7 juil. 2022 ... Meridian shareholders will receive $34 per share in cash, a 1.3% premium to the stock's closing price on Wednesday, under the deal. The ...8 juil. 2022 ... ... stock price prior to the offer. The all-cash transaction is expected to close in Q4, leaving SDB with a 60% stake and SJL with the remaining ...8 juil. 2022 ... ... stock price prior to the offer. The all-cash transaction is expected to close in Q4, leaving SDB with a 60% stake and SJL with the remaining ...
8 fév. 2022 ... Special Sign on Equity Award: We are pleased to offer you 7,500 RSUs, and 5,000 Options upon hire, pursuant to the Meridian Stock Incentive Plan ...
Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has entered into a side letter with the buyer ...
Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ...28 août 2021 ... Get the latest news and market analysis for Meridian Bioscience, Inc. (VIVO). Stay up-to-date on VIVO Stock price and share price with ...Feb 1, 2023 · Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms ... Jul 7, 2022 · Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ... 8 juil. 2022 ... ... Meridian Bioscience Inc. for about 2 trillion won (US$1.53 billion) in ... Korea suspends stock short selling until start of July 2024 · Most ...Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $0.
Fast 1-Step RT-qPCR Mix. Fast 1-Step RT-qPCR master mix contains Taq polymerase, reaction buffer, dNTP, MgCl 2, stabilizers, PCR enhancers, and separate reverse transcriptase and RNase inhibitor. It is ideal for developing multiplex one-step qPCR diagnostic tests and is suited for high-throughput, automated platforms. Request a Sample.Jan 31, 2023 · The estimated Net Worth of Dwight E Ellingwood is at least $379 Thousand dollars as of 4 October 2018. Mr. Ellingwood owns over 1,000 units of Meridian Bioscience stock worth over $271,760 and over the last 9 years he sold VIVO stock worth over $0. In addition, he makes $107,000 as Independent Director at Meridian Bioscience.Jan 31, 2023 · The estimated Net Worth of Catherine Sazdanoff is at least 365 千$ dollars as of 29 April 2016. Ms. Sazdanoff owns over 7,700 units of Meridian Bioscience stock worth over 261,569$ and over the last 8 years she sold VIVO stock worth over 0$. In addition, she makes 103,333$ as Independent Director at Meridian Bioscience.Meridian Bioscience Stock Hits New 52-Week High (VIVO) thestreet.com - March 26 at 5:22 PM Phoenix Union Bioscience High School usnews.com - March 23 at 3:29 PM Global "Diagnostics PCR Market" 2023: On-going Trends and Growth Insights by 2027 marketwatch.com - March 20 at 6:42 PM Marviette Johnson VIVO stock SEC Form 4 insiders trading. Marviette has made over 1 trades of the Meridian Bioscience stock since 2015, according to the Form 4 filled with the SEC. Most recently Marviette sold 1,917 units of VIVO stock worth $38,167 on 2 March 2015.. The largest trade Marviette's ever made was selling 1,917 units of …
Dec 31, 2022 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies ...
Curian is a rapid diagnostic solution for immunoassay detection of gastrointestinal diseases. It quickly and accurately identifies H. pylori, Campylobacter, and Shiga Toxin E. coli active infections. New tests are continuously being added to improve gastrointestinal outcomes and build a healthier community.7 juil. 2022 ... Neither acquirer issued their own statements on the transaction. Meridian's stock opened at $33.21 on the news on Thursday. The acquisition ...Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...Jan 31, 2023 · The estimated Net Worth of James M. Anderson is at least $1.07 Million dollars as of 6 January 2023. Mr. Anderson owns over 8,500 units of Meridian Bioscience stock worth over $958,769 and over the last 14 years he sold VIVO stock worth over $0. In addition, he makes $114,667 as Independent Director at Meridian Bioscience.With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Meridian Bioscience Stock Forecast and Price Target. According to experts, who recently provided their 2023 price targets for Meridian Bioscience, the average price target is $20.64, with a high estimate of $23.12 and a low estimate of $18.37. That is a potential upside of approximately 68,700% from the last closing price of $0.03 …Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Insiders trading at Meridian Bioscience. Over the last 21 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny, and John A Kraeutler.On average, Meridian Bioscience …(NASDAQ: VIVO). FOCUS represented Bioline in this transaction. The acquisition included the purchase of all the outstanding capital stock of the Bioline group ...Ms Lueke VIVO stock SEC Form 4 insiders trading. Ms has made over 4 trades of the Meridian Bioscience stock since 2012, according to the Form 4 filled with the SEC. Most recently she bought 4,000 units of VIVO stock worth $50,360 on 2 February 2017.. The largest trade she's ever made was exercising 21,000 units of Meridian …
Looking at the universe of stocks we cover at Dividend Channel, on 8/1/13, Meridian Bioscience Inc. (NASD: VIVO) will trade ex-dividend, for its quarterly dividend of $0.19, payable on 8/15/13.
Jul 18, 2022 · Meridian Bioscience announced July 7 it's entered into a definitive merger agreement to be acquired by a pair of South Korean-based firms, SD Biosensor and SJL Partners, in a deal valued at $1.53 ...
27 Apr 2018 ... Meridian Bioscience Brand Essence Video. 1.1K views · 5 years ago ...more. Meridian Bioscience. 350. Subscribe. 350 subscribers.As a publicly traded company, ownership of Meridian Bioscience, Inc. is constantly changing as shares are bought and sold on the stock market.Meridian Bioscience, Inc. (VIVO) Mission Statement The mission of Meridian Bioscience, Inc. is to provide diagnostic test kits, reagents, and related products and services that are of the highest quality ...Meridian Bioscience Inc. Common Stock (VIVO) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets.7 juil. 2022 ... Neither acquirer issued their own statements on the transaction. Meridian's stock opened at $33.21 on the news on Thursday. The acquisition ...Newark, New Castle, USA, June 09, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global chronic hepatitis B virus testing market was conducted by Growth Plus Reports in 2022 and valued at US$ 816.10 million. The market is expected to hit a revenue CAGR of 6.3% to reach US$ 1,498.24 million by 2031. Jun 8, 2023.Curian is a rapid diagnostic solution for immunoassay detection of gastrointestinal diseases. It quickly and accurately identifies H. pylori, Campylobacter, and Shiga Toxin E. coli active infections. New tests are continuously being added to improve gastrointestinal outcomes and build a healthier community.Meridian Bioscience has 5 employees across 11 locations and $333.02 m in annual revenue in FY 2022. See insights on Meridian Bioscience including office locations, competitors, ... Stock Price. $34. 2023-01-30. Market Capitalization. $1.5 B. 2023-01-30. Revenue. $333 M. FY, 2022.Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...A-. Diagnostic testing solutions provider Meridian Bioscience, Inc. ( VIVO ), recently announced that it has entered into a definitive agreement to acquire Otsuka America Pharmaceutical’s North American BreathTek business for $20 million. The deal is likely to close in Meridian’s fiscal fourth quarter. Following the news release, shares of ...Dec 13, 2022 · A high-level overview of Meridian Bioscience, Inc. (VIVO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Jan 31, 2023 · The estimated Net Worth of James M. Anderson is at least $1.07 Milion dollars as of 6 January 2023. Mr. Anderson owns over 8,500 units of Meridian Bioscience stock worth over $958,769 and over the last 14 years he sold VIVO stock worth over $0. In addition, he makes $114,667 as Independent Director at Meridian Bioscience.
Feb 1, 2023 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ... Meridian Bioscience sets closing date for $1.53 billion deal finance.yahoo.com - December 12 at 5:59 PM: Meridian Bioscience (NASDAQ:VIVO) Stock Rating Reaffirmed by William Blair marketbeat.com - November 29 at 8:16 AM: Meridian Bioscience Non-GAAP EPS of $0.21, revenue of $65.67M seekingalpha.com - November 22 at 5:12 PMMeridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected] stock is in the headlines as the company discloses a financial update. Meridian Bioscience ( VIVO) agreed to be acquired by SD Biosensor and SJL Partners in a $1.53 billion deal. Also, the ...Instagram:https://instagram. ktos stock forecastplanning firmsishares msci eafehow to short sell on robinhood Mr. Ellingwood VIVO stock SEC Form 4 insiders trading. Dwight has made over 6 trades of the Meridian Bioscience stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 1,000 units of VIVO stock worth $12,800 on 4 October 2018.. The largest trade he's ever made was exercising 3,000 units of Meridian …The standard meridian of India is 82.5 degrees east of the Greenwich Meridian. This meridian passes through the city of Allahabad. It runs through the center of the country. In 1905, this longitude was selected as the meridian to create the... forst energyvwo dividend TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com dollas tree Current and historical p/e ratio for Meridian Bioscience Inc. (VIVO) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used ...Looking at the universe of stocks we cover at Dividend Channel, on 8/1/13, Meridian Bioscience Inc. (NASD: VIVO) will trade ex-dividend, for its quarterly dividend of $0.19, payable on 8/15/13. The opportunity to support authentic relationships is what motivates our teams to create accurate solutions that span the range from discovery to diagnosis. We work hard every day to build genuine connections with all of our customers because even in the complex world of healthcare, the solution is simple. We’re here to help people, and we ...